Form D · Other Technology

EBI Life Sciences, Inc.

Cambridge, MA · CIK 0001544177

Offering snapshot reported May 30, 2012 · SEC filing

Reported sold: $27.3K
Investors reported: 7
Minimum accepted: $140
First sale: Mar 2, 2012

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$9,341 → $27,318
Reported investors6 → 7

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
May 30, 2012	Amendment	$27,318	$17,977vs Mar 16, 2012	7	SEC filing
Mar 16, 2012	Initial	$9,341	No comparison	6	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-175100

The offering closed in 2 separate tranches. Tranche 1 ($9,341) closed 3/2/12, and tranche 2 ($17,977) closed 5/15/12.

Source: Form D, filed May 30, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Andrew Baker	Director
Timothy J. Barberich	Director
Franklin P. Bymaster	Executive
Joshua Funder	Director
Frank Gentile	Director
Anthony A. Mc Kinney	Director, Executive
Campbell Murray	Director
Thomas A. Shea	Executive
Pierre Tran	Executive
Paul Weiss	Director

Issuer details

Industry: Other Technology (See others in industry)

Address:

43 Thorndike Street Suite S1 3
Cambridge, MA, 02141